Tandem Diabetes Care (TNDM) Short term Debt (2024 - 2025)
Tandem Diabetes Care's (TNDM) quarterly Short term Debt came in at $40.7 million in Q1 2025, little changed quarter-over-quarter from $40.7 million in Q4 2024.
Analysis
Tandem Diabetes Care (TNDM) Short term Debt (2024 - 2025) Analysis & Trends
Tandem Diabetes Care (TNDM) has reported Short term Debt for 2 consecutive years, with $40.7 million the latest figure, recorded in Q1 2025.
- For the quarter ending Q1 2025, Short term Debt changed N/A year-over-year to $40.7 million; the trailing twelve-month figure through Mar 2025 stood at $40.7 million (changed N/A YoY), and the FY2024 full-year result was $40.7 million, changed N/A from the prior year.
- Short term Debt was little changed at $40.7 million in Q1 2025 per TNDM's latest filing, from $40.7 million in the prior quarter.
- Across five years, Short term Debt topped out at $40.7 million in Q1 2025 and bottomed at $40.5 million in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.27 Bn | 811.05 Mn | 144.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 40.74 Mn |
| Dec 31, 2024 | 40.67 Mn |
| Sep 30, 2024 | 40.61 Mn |
| Jun 30, 2024 | 40.54 Mn |